Population Pharmacokinetics of Tapentadol Immediate Release (IR) in Healthy Subjects and Patients with Moderate or Severe Pain

Author： >  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.49, Iss.10, 2010-10, pp. : 671-682

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tapentadol Immediate Release: A Review of its Use in the Treatment of Moderate to Severe Acute Pain

By Frampton James E.  

Drugs, Vol. 70, Iss. 13, 2010-09 ,pp. : 1719-1743

Adis International

Access to resources Recommend Favorite

Tapentadol immediate- and extended-release: a guide to its use in acute and chronic pain

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 12, 2011-12 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of Onercept in Healthy Subjects

By Glatt Sophie   Fuseau Eliane  

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1295-1304

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee: A Randomized, Double-Blind, Placebo- and Active-Controlled Phase III Study

By Afilalo Marc  

Clinical Drug Investigation, Vol. 30, Iss. 8, 2010-08 ,pp. : 489-505

Adis International

Access to resources Recommend Favorite

Analgesic Efficacy and Tolerability of Tramadol 100mg Sustained-Release Capsules in Patients with Moderate to Severe Chronic Low Back Pain

By Raber M.  

Clinical Drug Investigation, Vol. 17, Iss. 6, 1999-06 ,pp. : 415-423

Adis International

Access to resources Recommend Favorite